+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Huntingtin"

Huntington's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Huntington's Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 150 Pages
  • Global
From
Huntington's Disease Treatment Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Huntington's Disease Treatment Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 145 Pages
  • Global
From
From
Market Spotlight: Huntington's Disease - Product Thumbnail Image

Market Spotlight: Huntington's Disease

  • Report
  • January 2021
  • 32 Pages
  • Global
Huntingtin - Pipeline Review, H2 2020 - Product Thumbnail Image

Huntingtin - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 93 Pages
  • Global
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Huntingtin is a protein found in the central nervous system (CNS) that is associated with Huntington's disease, a rare, inherited neurological disorder. The Huntingtin market is a subset of the CNS drugs market, which is focused on developing treatments for neurological disorders. The Huntingtin market is composed of companies that are researching and developing drugs to treat Huntington's disease. These drugs are designed to reduce the production of the mutated Huntingtin protein, which is responsible for the symptoms of the disease. The Huntingtin market is a relatively small market, but it is growing as more companies enter the space. Companies in the Huntingtin market include Ionis Pharmaceuticals, Roche, Novartis, and Sanofi. These companies are researching and developing drugs to treat Huntington's disease, as well as other neurological disorders. Show Less Read more